BIOMAT Database Logo BIOMAT Database Logo

Crystal structure of human ISG20, an interferon-induced antiviral ribonuclease. 2004

Tatsuya Horio, and Masatoshi Murai, and Toshihiko Inoue, and Tomohiro Hamasaki, and Teruo Tanaka, and Tadaaki Ohgi
Research Laboratories, Nippon Shinyaku Co. Ltd, 3-14-1 Sakura, Tsukuba, Ibaraki 305-0003, Japan. t.horio@nippon-shinyaku.co.jp

ISG20 is an interferon-induced antiviral exoribonuclease that acts on single-stranded RNA and also has minor activity towards single-stranded DNA. It belongs to the DEDDh group of RNases of the DEDD exonuclease superfamily. We have solved the crystal structure of human ISG20 complexed with two Mn2+ ions and uridine 5'-monophosphate (UMP) at 1.9 A resolution. Its structure, including that of the active site, is very similar to those of the corresponding domains of two DEDDh-group DNases, the epsilon subunit of Escherichia coli DNA polymerase III and E. coli exonuclease I, strongly suggesting that its catalytic mechanism is identical to that of the two DNases. However, ISG20 also has distinctive residues, Met14 and Arg53, to accommodate hydrogen bonds with the 2'-OH group of the UMP ribose, and these residues may be responsible for the preference of ISG20 for RNA substrates.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D005092 Exonucleases Enzymes that catalyze the release of mononucleotides by the hydrolysis of the terminal bond of deoxyribonucleotide or ribonucleotide chains. Exonuclease,3'-5'-Exonuclease,3'-5'-Exonucleases,5'-3'-Exonuclease,5'-3'-Exonucleases,3' 5' Exonuclease,3' 5' Exonucleases,5' 3' Exonuclease,5' 3' Exonucleases
D005095 Exoribonucleases A family of enzymes that catalyze the exonucleolytic cleavage of RNA. It includes EC 3.1.13.-, EC 3.1.14.-, EC 3.1.15.-, and EC 3.1.16.-. EC 3.1.- Exoribonuclease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies

Related Publications

Tatsuya Horio, and Masatoshi Murai, and Toshihiko Inoue, and Tomohiro Hamasaki, and Teruo Tanaka, and Tadaaki Ohgi
Interferon-induced exonuclease ISG20 exhibits an antiviral activity against human immunodeficiency virus type 1.
August 2005, The Journal of general virology,
Tatsuya Horio, and Masatoshi Murai, and Toshihiko Inoue, and Tomohiro Hamasaki, and Teruo Tanaka, and Tadaaki Ohgi
The Interferon-Induced Exonuclease ISG20 Exerts Antiviral Activity through Upregulation of Type I Interferon Response Proteins.
September 2018, mSphere,
Tatsuya Horio, and Masatoshi Murai, and Toshihiko Inoue, and Tomohiro Hamasaki, and Teruo Tanaka, and Tadaaki Ohgi
Expression of interferon-stimulated gene 20 (ISG20), an antiviral effector protein, in glomerular endothelial cells: possible involvement of ISG20 in lupus nephritis.
December 2023, Renal failure,
Tatsuya Horio, and Masatoshi Murai, and Toshihiko Inoue, and Tomohiro Hamasaki, and Teruo Tanaka, and Tadaaki Ohgi
ISG20: an enigmatic antiviral RNase targeting multiple viruses.
June 2022, FEBS open bio,
Tatsuya Horio, and Masatoshi Murai, and Toshihiko Inoue, and Tomohiro Hamasaki, and Teruo Tanaka, and Tadaaki Ohgi
ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses.
May 2003, The Journal of biological chemistry,
Tatsuya Horio, and Masatoshi Murai, and Toshihiko Inoue, and Tomohiro Hamasaki, and Teruo Tanaka, and Tadaaki Ohgi
Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA.
April 2017, PLoS pathogens,
Tatsuya Horio, and Masatoshi Murai, and Toshihiko Inoue, and Tomohiro Hamasaki, and Teruo Tanaka, and Tadaaki Ohgi
[Antiviral activities of ISG20 against hepatitis C virus].
January 2013, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
Tatsuya Horio, and Masatoshi Murai, and Toshihiko Inoue, and Tomohiro Hamasaki, and Teruo Tanaka, and Tadaaki Ohgi
The interferon stimulated gene 20 protein (ISG20) is an innate defense antiviral factor that discriminates self versus non-self translation.
October 2019, PLoS pathogens,
Tatsuya Horio, and Masatoshi Murai, and Toshihiko Inoue, and Tomohiro Hamasaki, and Teruo Tanaka, and Tadaaki Ohgi
[ISG20: An antiviral factor able to discriminate self versus non-self translation].
November 2021, Medecine sciences : M/S,
Tatsuya Horio, and Masatoshi Murai, and Toshihiko Inoue, and Tomohiro Hamasaki, and Teruo Tanaka, and Tadaaki Ohgi
Crystal structure of the 2'-specific and double-stranded RNA-activated interferon-induced antiviral protein 2'-5'-oligoadenylate synthetase.
November 2003, Molecular cell,
Copied contents to your clipboard!